T2 Biosystems Announces First Quarter 2023 Financial Results

LEXINGTON, Mass., May 23, 2023 -- T2 Biosystems, Inc.  , a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced financial results for the... | May 23, 2023

Related Keywords

, John Sperzel , Lyme Panel , Biothreat Panel , Company Annual Report On Form , Exchange Commission , Nasdaq , While The Company , Gilmartin Group , Resistance Panel , Biosystems Inc , Globenewswire Inc , Device Designation , Medical Affairs , Conference Call , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports , Trip Taylor , T2 Biosystems , Nc Stock Exchange , News , Information , Press Release , Bay , 023 , 2 , Leader , N , The , Rapid , Detection , F , Pathogens , End , Ntibiotic , Resistance , Oday , Nnounced , Financial , Results , Or Ttoo Us89853l2034 ,